Tonight, we resume our look at the genome, the science of D-N-A, the genetic code for life as we know it. We’ll look at recent advances — and setbacks — for the once promising field of genetic-based personal medicine, including the FDA’s decision to shut down medical predictions by 23-and-me, a well-known consumer genetic company.